Brief: Eloxx Pharmaceuticals Granted Extension By Nasdaq To Regain Compliance With The Market Value Of Listed Securities Continued Listing Requirement

Eloxx Pharmaceuticals

06/06/2023 14:15

June 6 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS GRANTED EXTENSION BY NASDAQ TO
REGAIN
COMPLIANCE WITH THE MARKET VALUE OF LISTED SECURITIES CONTINUED
LISTING REQUIREMENT

Source text for Eikon:  ID:nGNX1P7ZDv 
Further company coverage:  ELOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))